Bulletin
Investor Alert

Dec. 30, 2021, 3:32 a.m. EST

Rapid Testing Kits Market- Overview by Manufactures, Business Analysis, Opportunity, Industry Growth, and Forecast to 2028

new
Watchlist Relevance
LEARN MORE

Want to see how this story relates to your watchlist?

Just add items to create a watchlist now:

  • X
    Abbott Laboratories (ABT)
  • X
    Meridian Bioscience Inc. (VIVO)
  • X
    Qiagen N.V. (QGEN)

or Cancel Already have a watchlist? Log In

Dec 30, 2021 (AmericaNewsHour) -- Research Nester published a report titled "Rapid Testing Kits Market: Global Demand Analysis & Opportunity Outlook 2028" which delivers a detailed overview of the rapid testing kits market in terms of market segmentation by product type, by application, by end-user, and by region.

The global rapid testing kits market speak of rapid medical diagnostic test kits, appropriate for preliminary or emergency medical inspection, and demand in medical provisions with limited resources. They provide results in 2 hours. Attributable to fast results and ease of use provided by these kits, it is possible to offer well-timed treatment.

However, the likelihood of faulty results, stringent& time-consuming approval policies and a hesitation to shift from existing diagnostic practices are anticipated to restrain the market growth.

The rapid testing kits market is estimated to attain a notable CAGR during the forecast period, i.e., 2020-2028. The market is segmented by product type, application, end-user, and region. The global need for antibody testing kits to contain the COVID 19 pandemic has created significant growth opportunities in the global rapid testing market owing to soaring confirmed cases that are going beyond control and there is a major shortage of these test kits all across the globe. Many private companies have begun manufacturing rapid test kits to sustain the massive demand.

Access Full Report, here: https://www.researchnester.com/sample-request-2687

There have been many instances where the results were false-negative and false-positive.

The Indian Council of Medical Research (ICMR) on April 27, 2020, directed states to stop the usage of rapid antibody test kits that were procured from China-based Guangzhou Wondfo Biotech and Zhuhai Livzon Diagnostics after they showed wide variations in results.

Additionally, strict & time-consuming approval policies, and a hesitation to change existing diagnostic practices are anticipated to restrain the market growth.

This report also provides the existing competitive scenario of some of the key players of the rapid testing kits which includes company profiling of BioMedomics, Altona Diagnostics, Abbott Laboratories /zigman2/quotes/203724446/composite ABT +0.71% , BioMerieux (epa:BIM), Roche Diagnostics (swx:RO), Meridian Bioscience /zigman2/quotes/202928219/composite VIVO -1.15% , Cepheid, MyLab, Qiagen /zigman2/quotes/204869908/composite QGEN +1.84% , AccuBioTech. The profiling enfolds key information of the companies which encompasses business overview, products and services, key financials, and recent news and developments.

For more information about this report visit: https://www.researchnester.com/sample-request-2687

About Research Nester

Research Nester is a leading service provider for strategic market research and consulting. We aim to provide unbiased, unparalleled market insights and industry analysis to help industries, conglomerates and executives to take wise decisions for their future marketing strategy, expansion and investment etc. We believe every business can expand to its new horizon, provided a right guidance at a right time is available through strategic minds. Our out of box thinking helps our clients to take wise decision in order to avoid future uncertainties.

Contact Us

AJ Daniel
Email:  info@researchnester.com
U.S. Phone: [+1 646 586 9123]
U.K. Phone: [+44 203 608 591]

The post Rapid Testing Kits Market- Overview by Manufactures, Business Analysis, Opportunity, Industry Growth, and Forecast to 2028 appeared first on America News Hour .

COMTEX_399834585/2606/2021-12-30T03:31:39

Is there a problem with this press release? Contact the source provider Comtex at editorial@comtex.com. You can also contact MarketWatch Customer Service via our Customer Center.

/zigman2/quotes/203724446/composite
US : U.S.: NYSE
$ 113.24
+0.80 +0.71%
Volume: 4.51M
May 20, 2022 4:03p
P/E Ratio
26.23
Dividend Yield
1.66%
Market Cap
$198.28 billion
Rev. per Employee
$393,929
loading...
/zigman2/quotes/202928219/composite
US : U.S.: Nasdaq
$ 25.77
-0.30 -1.15%
Volume: 212,067
May 20, 2022 4:00p
P/E Ratio
18.23
Dividend Yield
0.00%
Market Cap
$1.12 billion
Rev. per Employee
$446,430
loading...
/zigman2/quotes/204869908/composite
US : U.S.: NYSE
$ 45.27
+0.82 +1.84%
Volume: 1.49M
May 20, 2022 4:00p
P/E Ratio
19.45
Dividend Yield
N/A
Market Cap
$10.28 billion
Rev. per Employee
$383,683
loading...

This Story has 0 Comments
Be the first to comment

Story Conversation

Commenting FAQs »

Partner Center

Link to MarketWatch's Slice.